What is HumanFirst?
HumanFirst is dedicated to reducing human suffering by building the essential operational infrastructure required for decentralized clinical trials and distributed care models within patients' homes. The company's core mission involves a deep understanding of the needs of those who utilize, create, and are supported by its products, aiming to revolutionize healthcare delivery through innovative technology and patient-centric approaches.
How much funding has HumanFirst raised?
HumanFirst has raised a total of $12M across 1 funding round:
Series A
$12M
Series A (2021): $12M with participation from Arkitekt Ventures, Boost VC, Lux Capital, villageglobal.com, Maverick Ventures, and SV Angel
Key Investors in HumanFirst
Arkitekt Ventures
Arkitekt Ventures is an early-stage venture fund specializing in innovative healthcare delivery models and the application of frontier technology in medicine, investing in entrepreneurs dedicated to transforming advanced science and technology into solutions that significantly enhance human health.
Boost VC
Boost VC is a leading investor in deep tech, focusing on emerging and frontier categories. They provide funding primarily through Pre-Seed rounds and offer a Fellowship check for early-stage startups, supporting groundbreaking ideas across various innovative technologies.
Lux Capital
Lux Capital is a venture capital firm that invests in early-stage and growth-stage companies at the intersection of science and technology, backing founders in frontier areas such as AI, robotics, space, defense, biotechnology, and advanced materials.
What's next for HumanFirst?
The recent major strategic investment signals a pivotal growth phase for HumanFirst. This capital infusion is expected to accelerate the company's expansion of its decentralized trial infrastructure, enabling broader adoption of distributed care models. HumanFirst is poised to enhance its technological capabilities and market reach, further solidifying its position in transforming healthcare delivery and improving patient outcomes.
See full HumanFirst company page
